Health TrialsbyHealthPanel

Cultural Adaptation of Drug Treatment for DJJ Youth

ConditionSubstance Use
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-17
SponsorUniversity of California, San Francisco

About this trial

This project aims to improve the understanding of the impact of Ethnic and Racial Discrimination (ERD) on adolescent alcohol and other drug use (AOD) within the Black Justice-Involved Youth (JIY) population. Individual interviews with Black JIY and focus groups with parents and guardians of Black JIY and community members who support change and reform in the justice community for Black JIY will be conducted.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

A guardian of JIY

An advocate (someone who supports change and reform in the justice community) for Black JIY.

Between the ages of 13 and 17

Identify as Black or African American

Trial design

Design model

Sequential

Treatments tested in this trial

  • Culturally Adapted Adolescent Substance Use Treatment

    Behavioral

    The Cannabis Youth Treatment Series (CYT) (MET/CBT12 model) aims to reduce alcohol and cannabis use.

Treatment groups

55 Participants
are divided into 1 treatment group
Group A: ADAP-ITT Phase 8Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility and Acceptability

Participants will complete feasibility and acceptability questionnaires and provide qualitative data on likes and dislikes about the intervention, delivery, session structure, and content.

Time frame
After study completion, an average of 3 months

Secondary outcomes

1

Change in substance use

Participants will complete urinalysis

Time frame
Baseline, after each study visit, at study completion, up to 3 months post-intervention, an average of 6 months.
2

Change in mental health symptoms

Participants will complete measures and questionnaires to monitor anxiety, depression, and trauma symptoms

Time frame
Baseline, after each study visit, at study completion, up to 3 months post-intervention, an average of 6 months.
3

Change in discrimination distress

Participants will complete a discrimination distress assessment measure

Time frame
baseline, after study completion, and up to 3 months post-intervention, an average of 6 months.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of California, San Francisco

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

Source ClinicalTrials.gov
Apply now